Amneal Pharmaceuticals (NYSE:AMRX) reported second-quarter earnings of 9 cents per share, which missed the analyst consensus estimate of 14 cents by 35.71%. This is a 62.5% decrease over earnings of 24 cents per share from the same period last year.
The company reported quarterly sales of $404.642 million, which missed the analyst consensus estimate of $428.58 million by 5.59%. This is a 2.21% decrease over sales of $413.787 million the same period last year.
Amneal Pharmaceuticals lowered its fiscal year 2019 EPS guidance from 94 cents-$1.04 to 52 cents-62 cents versus a 61 cent estimate.
Amneal Pharmaceuticals closed Friday at $3.25. The stock has a 52-week high of $24.48 and a 52-week low of $3.18.
Related Links:
Arconic Trades Higher On Q2 Earnings Beat, Raised Guidance
Sealed Air Reports Mixed Q2 Earnings, Raises Guidance
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!